MG-2477 treatment resulted in similar cell death induction and reduction of viability in all tested neuroblastoma cell lines, independent of the stage derived from, the PKB or the MYCN status (Figure 1 and Supplementary Figure 1B) [31, 40, 46, 58]. This evidence concerns the gene MYCN and neuroblastoma.